Explore the collaborative relationship between Wnt/β-catenin and KRAS pathways in driving colorectal cancer development and progression.
Discover how FBXL16 protein stabilizes IRS1 signaling in KRAS-mutant lung adenocarcinomas, revealing new therapeutic targets for this challenging cancer.